Filing Details

Accession Number:
0000899243-22-036080
Form Type:
4
Zero Holdings:
No
Publication Time:
2022-11-16 21:53:57
Reporting Period:
2022-11-14
Accepted Time:
2022-11-16 21:53:57
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
742112 Invacare Corp IVC Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842) 952680965
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1535144 H Steven Rosen 25101 Chagrin Boulevard, Suite 350
Cleveland OH 44122
Yes No Yes Yes
1933086 Azurite Management Llc 25101 Chagrin Boulevard, Suite 350
Cleveland OH 44122
No No Yes Yes
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Shares, No Par Value Disposition 2022-11-14 60,480 $0.50 3,886,078 No 4 S Indirect As sole manager of Azurite Management LLC
Common Shares, No Par Value Disposition 2022-11-15 78,025 $0.50 3,808,053 No 4 S Indirect As sole manager of Azurite Management LLC
Common Shares, No Par Value Disposition 2022-11-16 20,000 $0.49 3,788,053 No 4 S Indirect As sole manager of Azurite Management LLC
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Indirect As sole manager of Azurite Management LLC
No 4 S Indirect As sole manager of Azurite Management LLC
No 4 S Indirect As sole manager of Azurite Management LLC
Footnotes
  1. The price reported in column 4 is a weighted average price. These common shares, no par value (the "Common Shares"), were sold in multiple transactions at prices ranging from $0.510 to $0.517, inclusive. The Reporting Persons undertake to provide to Invacare Corporation (the "Issuer"), any securityholder of the Issuer or the staff of the Securities and Exchange Commission ("SEC Staff"), upon request, full information regarding the number of shares sold at each price within the range specified herein.
  2. The price reported in column 4 is a weighted average price. These Common Shares were sold in multiple transactions at prices ranging from $0.500 to $0.505, inclusive. The Reporting Persons undertake to provide to the Issuer, any securityholder of the Issuer or the SEC Staff, upon request, full information regarding the number of shares sold at each price within the range specified herein.
  3. The price reported in column 4 is a weighted average price. These Common Shares were sold in multiple transactions at prices ranging from $0.490 to $0.493, inclusive. The Reporting Persons undertake to provide to the Issuer, any securityholder of the Issuer or the SEC Staff, upon request, full information regarding the number of shares sold at each price within the range specified herein.
  4. Azurite Management LLC ("Azurite") is the owner of record of all such Common Shares. Mr. Rosen, in his capacity as the sole manager of Azurite, has the ability to indirectly control the decisions of Azurite regarding the vote and disposition of securities held by Azurite, and as such may be deemed to have indirect beneficial ownership of the Common Shares held by Azurite. The Reporting Persons disclaim beneficial ownership of the Common Shares owned by Azurite, except to the extent of his pecuniary interest therein.
  5. This Form 4 is being filed as a result of sales of Common Shares by Azurite. The sales were effected at prices below the prices of the purchases reported in the Form 4s filed by the Reporting Persons on June 7, 2022 (as amended on June 8, 2022) and June 27, 2022, such that there is no profit for purposes of Section 16(b) and the rules promulgated thereunder.